GB0613566D0 - Crystalline sodium atorvastatin - Google Patents
Crystalline sodium atorvastatinInfo
- Publication number
- GB0613566D0 GB0613566D0 GB0613566A GB0613566A GB0613566D0 GB 0613566 D0 GB0613566 D0 GB 0613566D0 GB 0613566 A GB0613566 A GB 0613566A GB 0613566 A GB0613566 A GB 0613566A GB 0613566 D0 GB0613566 D0 GB 0613566D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- crystalline sodium
- sodium atorvastatin
- atorvastatin
- crystalline
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0613566A GB0613566D0 (en) | 2006-07-07 | 2006-07-07 | Crystalline sodium atorvastatin |
AU2006281229A AU2006281229A1 (en) | 2005-08-15 | 2006-08-14 | Crystalline and amorphous sodium atorvastatin |
NZ566286A NZ566286A (en) | 2005-08-15 | 2006-08-14 | Crystalline and amorphous sodium atorvastatin |
JP2008526538A JP2009542578A (en) | 2006-07-07 | 2006-08-14 | Crystalline and amorphous atorvastatin sodium |
PCT/GB2006/003025 WO2007020413A1 (en) | 2005-08-15 | 2006-08-14 | Crystalline and amorphous sodium atorvastatin |
EP06765276.8A EP1928823B1 (en) | 2005-08-15 | 2006-08-14 | Process for preparing crystalline sodium salt of ATORVASTATIN |
CA2619486A CA2619486C (en) | 2005-08-15 | 2006-08-14 | Crystalline and amorphous sodium atorvastatin |
BRPI0614279-6A BRPI0614279A2 (en) | 2005-08-15 | 2006-08-14 | crystalline and amorphous sodium atorvastatin |
US11/504,104 US8097734B2 (en) | 2005-08-15 | 2006-08-15 | Crystalline sodium atorvastatin |
US13/324,678 US8329922B2 (en) | 2005-08-15 | 2011-12-13 | Crystalline sodium atorvastatin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0613566A GB0613566D0 (en) | 2006-07-07 | 2006-07-07 | Crystalline sodium atorvastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0613566D0 true GB0613566D0 (en) | 2006-08-16 |
Family
ID=36926665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0613566A Ceased GB0613566D0 (en) | 2005-08-15 | 2006-07-07 | Crystalline sodium atorvastatin |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2009542578A (en) |
GB (1) | GB0613566D0 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3444664A1 (en) | 2010-12-08 | 2019-02-20 | View, Inc. | Improved spacers for insulated glass units |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
CA2560282A1 (en) * | 2004-03-17 | 2005-09-29 | Ranbaxy Laboratories Limited | Crystalline form of atorvastatin hemi calcium |
PT1727795E (en) * | 2004-03-17 | 2012-04-11 | Ranbaxy Lab Ltd | Process for the production of atorvastatin calcium in amorphous form |
ES2739493T3 (en) * | 2004-05-05 | 2020-01-31 | Pfizer Prod Inc | Salt forms of atorvastatin with benetamine |
WO2006032959A2 (en) * | 2004-08-06 | 2006-03-30 | Glenmark Pharmaceuticals Limited | Processes for the preparation of pyrrole derivatives |
JP2008510798A (en) * | 2004-08-27 | 2008-04-10 | バイオコン・リミテッド | Method for amorphous atorvastatin calcium |
CN100503564C (en) * | 2005-08-15 | 2009-06-24 | 浙江新东港药业股份有限公司 | Process for preparing high purity crystal atorvastatin sodium |
-
2006
- 2006-07-07 GB GB0613566A patent/GB0613566D0/en not_active Ceased
- 2006-08-14 JP JP2008526538A patent/JP2009542578A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2009542578A (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1900033I1 (en) | Substituted enaminocarbonyl compounds | |
ZA200808639B (en) | Oxadiazolidinedione compound | |
GB0602424D0 (en) | Compounds | |
GB0602046D0 (en) | Compounds | |
EP1985620A4 (en) | 10a-AZALIDE COMPOUND | |
EP1984379A4 (en) | Anti-arenaviral compounds | |
EP2000469A4 (en) | Acylaminopiperidine compound | |
ZA200903614B (en) | New crystalline forms | |
GB0607096D0 (en) | Compound | |
EP2082022A4 (en) | Compounds | |
IL188219A0 (en) | Crystalline form rabeprazole sodium | |
IL195061A0 (en) | Crystalline forms of atorvastatin | |
EP2004174A4 (en) | Naphthalenedione compounds | |
GB0604142D0 (en) | Compound | |
GB0602042D0 (en) | Compounds | |
ZA200806859B (en) | Novel crystalline compounds | |
EP1973905A4 (en) | Compounds | |
GB0613566D0 (en) | Crystalline sodium atorvastatin | |
ZA200901570B (en) | Substituted azolin-2-YL-amino compounds | |
EP2016069A4 (en) | Bis-pyridinium compounds | |
GB0602560D0 (en) | Compounds | |
GB0602412D0 (en) | Compounds | |
GB0600427D0 (en) | Compounds | |
GB0613567D0 (en) | Crystalline sodium atorvastatin | |
HU0600120D0 (en) | New crystalline atorvastatin hemicalcium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |